HC Wainwright & Co. Maintains Buy on Rockwell Medical, Raises Price Target to $11
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Raghuram Selvaraju maintains a 'Buy' rating on Rockwell Medical (NASDAQ:RMTI) and raises the price target from $9 to $11.
July 17, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rockwell Medical's price target has been raised from $9 to $11 by HC Wainwright & Co. The firm maintains a 'Buy' rating on the stock.
The increase in price target by HC Wainwright & Co. indicates a positive outlook for Rockwell Medical. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100